Novartis CEO warned U.S. biotech curbs on China could slow drug development

Summary
Vas Narasimhan said Treasury's proposed investment limits would hinder moving technologies between U.S. and Chinese operations
Description from Quartz.
Who is covering this
-
Novartis CEO warned U.S. biotech curbs on China could slow drug development
Vas Narasimhan said Treasury's proposed investment limits would hinder moving technologies between U.S. and Chinese operations
Comments
Comments need JavaScript.